The global influenza diagnostics market is anticipated to grow at a CAGR of around 8.3% during the forecast period (2021-2027). The rising prevalence of influenza diseases, the growing geriatric population which is more prone to this disease, and the rising demand for early diagnosis are the major factors driving the growth of the market. According to the estimates of the Centers for Disease Control & Prevention, in 2019-2020, flu caused 38 million illnesses, 400,000 hospitalizations, and 22,000 deaths in the US. The demand for point-of-care diagnosis solution and effective diagnostic kits has increased in the last few years due to growing concern and awareness for the treatments. To fulfil the market needs and customer demands, various authorities giving fund for the development of drugs and companies also taking initiatives by launching new molecular diagnostic kits.
To Request a Sample of our Report on Influenza Diagnostics Market: https://www.omrglobal.com/request-sample/influenza-diagnostics-market
In February 2021, Luminex Corp. has received a fund of $11.3 millionfrom the US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA). The fund was given to support the development and validation of a multiplex respiratory panel for flu A/B, respiratory syncytial virus (RSV), and SARS-CoV-2 targets on its Aries systems. Moreover, in June 2020, Cepheid announced the development of a next-generation Xpert Xpress SARS-CoV-2/Flu/RSV four-in-one test for the detection of SARS-CoV-2, Flu A, Flu B and RSV from a single patient sample. Similarly, in February 2020, Abbott Laboratories had launched a new inactivated quadrivalent vaccine for influenza that offers protection against four virus strains in India. Besides, these product developments, the Enormous Funding and Investment by the government for the R&D of influenza diagnostics further projected to create lucrative opportunities to the market.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Test Type
- By End-User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- CompetitiveLandscape- F. Hoffmann-La Roche Ltd, Quidel Corp., Thermo Fisher Scientific Inc., Abbott Laboratories, Luminex Corp., Becton, Dickinson and Co., among Others.
(Get 15% Discount on Buying this Report)
A full Report of Influenza Diagnostics Market is Available at: https://www.omrglobal.com/industry-reports/influenza-diagnostics-market
Global Influenza Diagnostics Market Report Segment
By Test Type
- Molecular Diagnostic Assays
- RT-PCR
- LAMP
- NASBA
- SAMBA
Traditional Diagnostic Tests
- Rapid Influenza Diagnostic Tests (RIDT)
- Serological Assay
- Viral Culture
- By End-User
- Hospitals & Diagnostic Centers
- Research & Academic Institutes
- Contract Research Organizations (CROS)
